First National Bank Sioux Falls Abb Vie Inc. Transaction History

First National Bank Sioux Falls

$217 Million
Q3 2024

A detailed history of First National Bank Sioux Falls transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Bank Sioux Falls holds 6,113 shares of ABBV stock, worth $1.08 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

6,113

Previous 6,113 -0.0%

Holding current value

$1.08 Million

Previous $1.05 Million 15.17%

% of portfolio

0.56%

Previous 0.55%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $15,982 - $18,210	-100 Reduced 1.61%	6,113 $1.11 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $4,265 - $4,804	-31 Reduced 0.5%	6,213 $962,000
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $1,335 - $1,546	-10 Reduced 0.16%	6,244 $930,000
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $23,851 - $29,682	-180 Reduced 2.8%	6,254 $842,000
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $723 - $832	-5 Reduced 0.08%	6,434 $1.03 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $90,316 - $108,313	-653 Reduced 9.21%	6,439 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $164,138 - $188,256	-1,223 Reduced 14.71%	7,092 $952,000
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $6,881 - $8,748	-50 Reduced 0.6%	8,315 $1.27 Million
Q1 2022 Apr 08, 2022	SELL	$131.98 - $163.75 $12,934 - $16,047	-98 Reduced 1.16%	8,365 $1.36 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $280,392 - $354,777	2,610 Added 44.59%	8,463 $1.15 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $1,052 - $1,172	-10 Reduced 0.17%	5,853 $659,000
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $68,950 - $75,905	674 Added 12.99%	5,863 $635,000
Q4 2020 Jan 11, 2021	BUY	$80.49 - $108.67 $109,466 - $147,791	1,360 Added 35.52%	5,189 $556,000
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $4,548 - $6,087	-62 Reduced 1.59%	3,829 $376,000
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $29,025 - $44,005	-450 Reduced 10.37%	3,891 $297,000
Q4 2019 Jan 10, 2020	BUY	$72.13 - $90.25 $49,769 - $62,272	690 Added 18.9%	4,341 $384,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $20,594 - $24,760	-327 Reduced 8.22%	3,651 $277,000
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $9,198 - $11,757	-140 Reduced 3.4%	3,978 $290,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $7,328 - $8,625	-95 Reduced 2.25%	4,118 $332,000
Q4 2018 Jan 09, 2019	BUY	$77.85 - $96.01 $11,288 - $13,921	145 Added 3.56%	4,213 $388,000
Q3 2018 Oct 18, 2018	BUY	$88.91 - $98.84 $35,208 - $39,140	396 Added 10.78%	4,068 $385,000
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $2,424 - $2,868	-27 Reduced 0.73%	3,672 $340,000
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $28,523 - $38,195	-310 Reduced 7.73%	3,699 $350,000
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $37,077 - $40,658	-414 Reduced 9.36%	4,009 $387,000
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $308,946 - $394,620	4,423	4,423 $393,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Sioux Falls, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Sioux Falls with notifications on news.

Account

First National Bank Sioux Falls Abb Vie Inc. Transaction History